Andrew Schmidt, MD
Orthopaedic Surgery · Minneapolis, MNNPI 1033115118
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.2%), food and beverage and royalties or licence payments — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Synthes GmbH at 48.4% of the total. Reporting peaked in 2019 at $4,530 and has fallen 95.0% since, to $229 in 2025.
Across 40 payments — averaging $162.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$3K
- Stryker$1K
- Smith+Nephew$971
- My01 Inc.$186
- Globus Medical$149
- Integra Lifesciences Corporation$144
- plus $561 from 6 others
What the payments were for
- Royalty or licence$78912%
- Consulting fees$1252%
- Speaking & faculty fees$3,00046%
- Travel & lodging$3616%
- Food & beverage$2,21434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 3 | $3,138 |
| Stryker | 16 | $1,339 |
| Smith+Nephew | 9 | $971 |
| My01 Inc. | 2 | $186 |
| Globus Medical | 2 | $149 |
| Integra Lifesciences Corporation | 1 | $144 |
| Johnson & Johnson | 1 | $131 |
| Medacta USA, Inc. | 2 | $127 |
| Acumed LLC | 1 | $125 |
| Organogenesis Inc. | 1 | $111 |
| Onkos Surgical, Inc. | 1 | $52 |
| Si-bone, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CANNULATED SCREWS$789
- NONE$471
- INTEGRA$432
- GAMMA$172
- ADAPT$152
- MY01 Continuous Compartmental Pressure Monitor$151
- INTEGRA DERMAL REGENERATION TEMPLATE$144
- PRIMATRIX$144
- NA$131
- PuraPly$111
- Anthem$109
How this compares
$6,489 in reported general payments places this provider in the 60th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 25 | $120 |
| Ibuprofen | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Minneapolis
- David PollyMinneapolis$3.3M
- Ensor TransfeldtMinneapolis$2.3M
- Manuel PintoMinneapolis$1.7M
- Joseph PerraMinneapolis$1.6M
- Timothy GarveyMinneapolis$1.6M
- Amir MehbodMinneapolis$1.3M
- David TemplemanMinneapolis$361K
- Patrick YoonMinneapolis$203K
- Christopher MartinMinneapolis$131K
- Elizabeth ArendtMinneapolis$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.